Can berberine enhance glucose-stimulated insulin secretion in rat islets?

Nov 03, 2008

The therapeutical actions of berberine on diabetes have been well studied. Previous researches show that berberine modulates cholesterol through increasing low-density lipoprotein receptor mRNA stability, reduces body adiposity and increases insulin sensitivity partly through activating AMP-activated protein kinase and improves glucose metabolism via induction of glycolysis. Yet, the underlying mechanism for berberine promoting insulin release remains unclear.

A research article to be published on October 21, 2008 in the World Journal of Gastroenterology addresses this question. The research team was directed by Prof. Lu from Institute of integrative traditional and western medicine of Tongji medical college.

Using glucose-stimulated insulin secretion assay, the authors first examined the action of berberine on insulin secretion. Further, the authors detected the expression of HNF4 alpha on both gene and protein levels to examine if HNF4 alpha a candidate target of berberine. The role of HNF4 alpha in mediating berberine's insulinotropic effect was further elucidated by determining the activity of Glucokinase, the "Glucose Sensor" in pancreatic beta cell, which is also deemed as one of the downstream targets of the HNFs transcription regulatory circuit in pancreatic islets.

The results demonstrate that berberine only exerts insulinotropic effect in the high glucose condition, and berberine could enhance HNF4 alpha expression and GK activity dose-dependently.

The data of the research strongly suggested a correlation among insulin secretion, HNF4α expression and GK activity. The article proposes that berberine might facilitate glucose-stimulated insulin secretion in a pathway involving HNF4 alpha, which subsequently modulats the downstream targets such as glucokinase, resulting in increased sensitivity of beta cell to glucose challenge and insulin release.

Source: World Journal of Gastroenterology

Explore further: Researchers take 'first baby step' toward anti-aging drug

add to favorites email to friend print save as pdf

Related Stories

Madison, Wis., becoming a force in video game industry

4 hours ago

In the 20-plus years that Tim Gerritsen has been creating video games, working in the realm of imaginary battlefields and mythical kingdoms, the Wisconsin native has found himself in many of the real world's most innovative ...

LivingSocial's new CEO eyes an experience-oriented future

6 hours ago

Some big challenges lie ahead for LivingSocial, the online marketplace known for its daily deals and discounted prices on restaurants, spas and local activities. But that's where the company's new chief executive, Gautam ...

Recommended for you

Biomedical team creates 'nerve on a chip'

19 hours ago

Michael J. Moore and J. Lowry Curley first met in the laboratory as professor and student. Now the two Tulane University researchers have started a new biomedical company that's winning praise and awards.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.